Company Filing History:
Years Active: 2019
Title: Yolanda Pérez-Fuertes: Innovator in Modulating Tumor Necrosis Factor Activity
Introduction
Yolanda Pérez-Fuertes is a distinguished inventor based in Abingdon, GB. She has made significant contributions to the field of biopharmaceuticals, particularly in the modulation of tumor necrosis factor (TNF) activity. Her innovative work has the potential to impact various human ailments, making her a notable figure in the industry.
Latest Patents
Yolanda holds a patent for "Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity." This patent describes a series of substituted 3,4-dihydro-2H-1,4-benzoxazin-3-one derivatives and their analogs, which are identified as potent modulators of human TNFα activity. These compounds are beneficial in the treatment and prevention of a range of disorders, including autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders.
Career Highlights
Yolanda is currently employed at UCB Biopharma Sprl, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on addressing critical health challenges through her inventions.
Collaborations
Yolanda collaborates with esteemed colleagues, including Gareth Neil Brace and Prafulkumar Tulshibhai Chovatia. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in the biopharmaceutical field.
Conclusion
Yolanda Pérez-Fuertes is a pioneering inventor whose work in modulating tumor necrosis factor activity holds promise for treating various human ailments. Her contributions to the field of biopharmaceuticals exemplify the impact of innovative research on healthcare.